Share-based Payment Arrangement, Expense of OptimizeRx Corp from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
OptimizeRx Corp annual and quarterly Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • OptimizeRx Corp Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2023 was $2,913,809, a 28% increase year-over-year.
  • OptimizeRx Corp Share-based Payment Arrangement, Expense for the twelve months ending 31 Mar 2023 was $16,391,277, a 132% increase year-over-year.
  • OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2025 was $6,962,000, a 39% decline from 2024.
  • OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2024 was $11,467,000.
  • OptimizeRx Corp annual Share-based Payment Arrangement, Expense for 2022 was $15,745,822, a 187% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

OptimizeRx Corp Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $6,962,000 -$4,505,000 -39% 01 Jan 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
2024 $11,467,000 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
2022 $15,745,822 +$10,253,865 +187% 01 Jan 2022 31 Dec 2022 10-K 10 Mar 2023 2022 FY
2021 $5,491,957 +$2,319,117 +73% 01 Jan 2021 31 Dec 2021 10-K 10 Mar 2023 2022 FY
2020 $3,172,840 +$912,542 +40% 01 Jan 2020 31 Dec 2020 10-K/A 10 Mar 2023 2021 FY
2019 $2,260,298 -$260,554 -10% 01 Jan 2019 31 Dec 2019 10-K 08 Mar 2021 2020 FY
2018 $2,520,852 +$1,618,463 +179% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020 2019 FY
2017 $902,389 +$343,088 +61% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2019 2018 FY
2016 $559,301 -$21,805 -3.8% 01 Jan 2016 31 Dec 2016 10-K 08 Mar 2018 2017 FY
2015 $581,106 -$591,136 -50% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2017 2016 FY
2014 $1,172,242 +$648,860 +124% 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2016 2015 FY
2013 $523,382 01 Jan 2013 31 Dec 2013 10-K 16 Sep 2015 2014 FY

OptimizeRx Corp Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $16,391,277 $2,913,809 +$645,455 +28% 01 Jan 2023 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $15,745,822 $5,174,904 +$2,295,145 +80% 01 Oct 2022 31 Dec 2022 10-K 10 Mar 2023 2022 FY
Q3 2022 $13,450,677 $4,277,241 +$3,269,234 +324% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $10,181,443 $4,025,323 +$3,128,285 +349% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $7,053,158 $2,268,354 +$1,561,201 +221% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q4 2021 $5,491,957 $2,879,759 01 Oct 2021 31 Dec 2021 10-K 10 Mar 2023 2022 FY
Q3 2021 $1,008,007 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $897,038 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 $707,153 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.